跳至主要内容
临床试验/NCT00958399
NCT00958399已完成不适用

Satiety, Glycemic, and Gastrointestinal Effects of Novel Fibers

University of Minnesota2 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2008年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
2
主要终点
Satiety

研究概览

简要总结

Research suggests dietary fiber may play a role in weight management, and fiber consumption is inversely associated with body weight, body fat, and BMI in cross-sectional studies. These effects may be mediated by increased satiety, reduced food intake, or changes in blood levels of glucose, insulin, and gut hormones.

The purpose of this study is to determine the satiety, glycemic, hormonal, and gastrointestinal responses of novel fiber supplements.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy men and women
  • age 18-60 years
  • non-smoking
  • not taking medication
  • non-dieting (weight stable in prior 3 months)
  • BMI 18-27
  • English literacy
  • ability to give blood

排除标准

  • do not regularly consume breakfast
  • food allergies to ingredients found in study products
  • dislike for muffins, fiber bars, or hot cereal
  • BMI <18 or >27
  • diagnosed cardiovascular, renal, or hepatic disease
  • diabetes mellitus (fasting blood sugar >126 mg/dl)
  • cancer in previous 5 years (except basal cell carcinoma of the skin)
  • any gastrointestinal disease or condition
  • recent bacterial infection (< 3 months)
  • recent or concurrent participation in an intervention research study
  • history of drug or alcohol abuse in prior 6 months
  • use of lipid-lowering, anti-hypertensive, or anti-inflammatory steroid medication
  • restrained eaters
  • vegetarians
  • people who eat more than approximately 15 grams of fiber per day
  • women who are pregnant or lactating
  • women with irregular menstrual cycles

结局指标

主要结局

Satiety

时间窗: 0, 15, 30, 45, 60, 90, 120, 180, 215 minutes postprandially

次要结局

  • ad libitum food intake(180 minutes postprandially and over 24 hours)
  • Ghrelin, polypeptide YY (PYY), and glucagon-like peptide-1 (GLP-1) response(0, 30, 60 minutes postprandially)
  • Gastrointestinal tolerance and fecal chemistry(following 7 days of treatment)
  • Glucose/Insulin Response(0, 15, 30, 45, 60, 90, 120, 180 minutes postprandially)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验